AstraZeneca's statement late in the day said the company was striving to increase productivity to deliver the promised 180 million doses

Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week

The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support

The vaccine was also 98% effective in preventing fever or breathing problems and 98.9% effective in preventing hospitalizations and death, the ministry said

Russia has already approved two COVID-19 vaccines, Sputnik V and EpiVacCorona, which were also granted approval before seeing any late-stage trial results

As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.

Biden will also encourage G-7 partners to make good on their pledges to COVAX, an initiative by the World Health Organization to improve access to vaccines, according to a senior administration official

National Intelligence Service (NIS), the chief intelligence agency of South Korea informed lawmakers about the alleged cyber breach on Tuesday, February 16, during a closed-door briefing to a parliamentary intelligence committee

With no relief in sight from incessant rise in petrol and diesel prices, people turned to Twitter to vent their frustrations on the matter; The central government is set to notify the rules under new labour codes, which will have an impact on employees' cost to company (CTC) as well as employers' wage bills; Vaccination drive against COVID-19 and improving economic indicators have enthused employers to recruit. Watch this and more on News Blast.Also Read: Amazon to manufacture Fire TV Stick in India from this year

COVID-19 vaccine: The AstraZeneca-Oxford product is a viral vectored vaccine called ChAdOx1-S [recombinant], which is being produced at several manufacturing sites, as well as in the Republic of Korea and India

Earlier, Dr Reddy's had said it expects to roll out Sputnik V vaccine in India in March via Emergency Use Authorisation (EUA) after the completion of Phase 3 trials.

Legitimate questions about the virus created perfect conditions for conspiracy theories. In the absence of knowledge, guesswork and propaganda flourished

Earlier, The Lancet had stated that Russia's experimental COVID-19 vaccine Sputnik V is 91.6 per cent affective against coronavirus infection. These results are based on Phase 3 trials of the vaccine in which 20,000 people had participated

Russia's COVID-19 vaccine, Sputnik V, has shown 91.6 per cent efficacy in phase 3 trials with no serious side effects, as per an interim analysis published in The Lancet Journal; Oxford Languages has named 'Aatmanirbharta' as its Hindi Word of the Year 2020; Alibaba Group founder Jack Ma has been delisted from \"Chinese entrepreneurial leaders\" list published by the country's official state media. Watch this and more on News Blast. Also Read: RBI releases framework for risk-based internal audit of NBFCs, UCBs

Bharat Biotech will supply initial doses to be used in the US upon Ocugen's receipt of an EUA from the US regulatory authorities

The pharma stock touched an intraday high of Rs 4,759.1 rising 6.13% against previous close of Rs 4,484.25 on BSE

Oxford Languages names 'Aatmanirbharta' as Hindi Word of 2020 Oxford Languages has named 'Aatmanirbharta' as its Hindi Word of the Year 2020. The word gained significance after Prime Minister Narendra Modi emphasised on 'Aatmanirbharta' (self-reliance) as a response to the COVID-19 pandemic last year. According to the dictionary publisher, 'Aatmanirbharta' was chosen as it \"validated the day-to-day achievements of the countless Indians who dealt with and survived the perils of a pandemic\"...

The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors - recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).

The dosing mishap was presented to the trial participants in a letter dated June 8 as an opportunity for University of Oxford researchers to learn how well the vaccine works at different doses

Serum in its reply stated that both the companies operate in different product categories and there is no scope for confusion over the trademark